S. Tunç Et Al. , "Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study," Psychiatry and Clinical Psychopharmacology , vol.29, no.3, pp.307-314, 2019
Tunç, S. Et Al. 2019. Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study. Psychiatry and Clinical Psychopharmacology , vol.29, no.3 , 307-314.
Tunç, S., ATAGÜN, M. İ., Başbuğ, H. S., & EREL, Ö., (2019). Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study. Psychiatry and Clinical Psychopharmacology , vol.29, no.3, 307-314.
Tunç, Serhat Et Al. "Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study," Psychiatry and Clinical Psychopharmacology , vol.29, no.3, 307-314, 2019
Tunç, Serhat Et Al. "Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study." Psychiatry and Clinical Psychopharmacology , vol.29, no.3, pp.307-314, 2019
Tunç, S. Et Al. (2019) . "Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study." Psychiatry and Clinical Psychopharmacology , vol.29, no.3, pp.307-314.
@article{article, author={Serhat Tunç Et Al. }, title={Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study}, journal={Psychiatry and Clinical Psychopharmacology}, year=2019, pages={307-314} }